Skip to main content

ÖGMBT-Young Life Scientists Austria/FEBS Junior Sections present Florian Rüker



This talk titled 'Circumventing immunisation by in vitro directed evolution and selection of human antibodies from large surface display libraries' is presented by the FEBS Junior Sections with invited speaker Prof. Florian Rüker from the University of Natural Resources and Life Sciences (BOKU), Vienna.

Monoclonal antibodies are currently the most important class of biological therapeutics. They are used for the treatment of a wide range of diseases, including cancer and autoimmune disorders. In the year 2018, ten monoclonal antibodies were among the 15 largest selling drugs worldwide. Adalimumab (Humira) has been the top selling drug for many years now and is a prime example for an antibody that was generated entirely by in vitro methods, completely circumventing immunisation. This seminar will focus on methods how this can be accomplished.

The FEBS Junior Sections is an initiative set up by students and young researchers from some of the FEBS Constituent Societies. Each month a Junior Section from one of the participant Societies organizes an online event on either an academic or a career topic. This May talk is organised by ÖGMBT-YLSA, the Junior Section of the Austrian Society.


This event is free to attend.


You can register to attend this event here.